FDA warns Citra100mg it sells unapproved, misbranded tramadol opioids without prescriptions to U.S. consumers online.
What happened
FDA reviewed www.citra100mg.com and observed it offering tramadol products marketed as Citra 100mg, Clovidol 100mg, Jpdol 100mg, Ol tram 100mg, OL-tram Loose Pills, and Trakem 100 mg. FDA says these are unapproved new drugs and misbranded because they lack FDA approval and adequate directions for use, and because prescription drugs are offered without a prescription. The letter describes a website review; it lists no inspection.
What FDA found
FDA says the website sells tramadol as an unapproved new drug, and no FDA-approved application is in effect for these named products.
FD&C Act sections 301(d), 505(a) [21 U.S.C. §§ 331(d), 355(a)]FDA says the products are prescription drugs but are offered without requiring a prescription.
FD&C Act sections 503(b)(1), 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]FDA says the labeling lacks adequate directions for use.
FD&C Act section 502(f)(1) [21 U.S.C. § 352(f)(1)]FDA says offering these drugs for sale causes misbranded drugs to enter interstate commerce.
FD&C Act section 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA asks Citra100mg to stop offering any unapproved and misbranded drugs to U.S. consumers and to notify FDA in writing within 15 working days of steps taken to correct violations and prevent recurrence.
Who should pay attention
- online pharmacies and websites selling prescription drugs to U.S. consumers
- companies that sell or distribute tramadol or other opioids
- regulatory teams monitoring internet drug sales and prescription requirements
This is a summary. Read the original letter on fda.gov.